lidocaine hci and epinephrine

Generic: lidocaine hci and epinephrine

Labeler: hf acquisition co llc, dba healthfirst
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name lidocaine hci and epinephrine
Generic Name lidocaine hci and epinephrine
Labeler hf acquisition co llc, dba healthfirst
Dosage Form INJECTION, SOLUTION
Routes
INFILTRATION PERINEURAL
Active Ingredients

epinephrine bitartrate .01 mg/mL, lidocaine hydrochloride anhydrous 20 mg/mL

Manufacturer
HF Acquisition Co LLC, DBA HealthFirst

Identifiers & Regulatory

Product NDC 51662-1505
Product ID 51662-1505_12048ce4-ce14-44c3-e063-6394a90ace48
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA006488
Listing Expiration 2026-12-31
Marketing Start 2020-03-11

Pharmacologic Class

Classes
adrenergic alpha-agonists [moa] adrenergic beta-agonists [moa] amide local anesthetic [epc] amides [cs] antiarrhythmic [epc] catecholamine [epc] catecholamines [cs] local anesthesia [pe] alpha-adrenergic agonist [epc] beta-adrenergic agonist [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 516621505
Hyphenated Format 51662-1505

Supplemental Identifiers

RxCUI
1010759
UPC
0363323483012
UNII
30Q7KI53AK EC2CNF7XFP

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name lidocaine hci and epinephrine (source: ndc)
Generic Name lidocaine hci and epinephrine (source: ndc)
Application Number NDA006488 (source: ndc)
Routes
INFILTRATION PERINEURAL
source: ndc

Resolved Composition

Strengths
  • .01 mg/mL
  • 20 mg/mL
source: ndc
Packaging
  • 50 mL in 1 VIAL, MULTI-DOSE (51662-1505-1)
  • 25 POUCH in 1 CASE (51662-1505-3) / 1 VIAL, MULTI-DOSE in 1 POUCH (51662-1505-2) / 50 mL in 1 VIAL, MULTI-DOSE
source: ndc

Packages (2)

Ingredients (2)

epinephrine bitartrate (.01 mg/mL) lidocaine hydrochloride anhydrous (20 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INFILTRATION", "PERINEURAL"], "spl_id": "12048ce4-ce14-44c3-e063-6394a90ace48", "openfda": {"upc": ["0363323483012"], "unii": ["30Q7KI53AK", "EC2CNF7XFP"], "rxcui": ["1010759"], "spl_set_id": ["a0997348-6274-060a-e053-2a95a90abea7"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "50 mL in 1 VIAL, MULTI-DOSE (51662-1505-1)", "package_ndc": "51662-1505-1", "marketing_start_date": "20200311"}, {"sample": false, "description": "25 POUCH in 1 CASE (51662-1505-3)  / 1 VIAL, MULTI-DOSE in 1 POUCH (51662-1505-2)  / 50 mL in 1 VIAL, MULTI-DOSE", "package_ndc": "51662-1505-3", "marketing_start_date": "20220317"}], "brand_name": "LIDOCAINE HCI AND EPINEPHRINE", "product_id": "51662-1505_12048ce4-ce14-44c3-e063-6394a90ace48", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Adrenergic alpha-Agonists [MoA]", "Adrenergic beta-Agonists [MoA]", "Amide Local Anesthetic [EPC]", "Amides [CS]", "Antiarrhythmic [EPC]", "Catecholamine [EPC]", "Catecholamines [CS]", "Local Anesthesia [PE]", "alpha-Adrenergic Agonist [EPC]", "beta-Adrenergic Agonist [EPC]"], "product_ndc": "51662-1505", "generic_name": "LIDOCAINE HCI AND EPINEPHRINE", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "LIDOCAINE HCI AND EPINEPHRINE", "active_ingredients": [{"name": "EPINEPHRINE BITARTRATE", "strength": ".01 mg/mL"}, {"name": "LIDOCAINE HYDROCHLORIDE ANHYDROUS", "strength": "20 mg/mL"}], "application_number": "NDA006488", "marketing_category": "NDA", "marketing_start_date": "20200311", "listing_expiration_date": "20261231"}